Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites

Journal of Controlled Release

Volumn 84, Issue 3, 2002, Pages 137-150

  Hedberg, Elizabeth L ^a   Tang, Andrew ^b   Crowther, Roger S ^b   Carney, Darrell H ^b   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b Chrysalis BioTechnology Inc   (United States)

Author keywords

Biodegradable polymers; Bone tissue engineering; Composite scaffolds; PLGA microparticles; Poly(propylene fumarate)

Indexed keywords

MACROGOL; MEDISORB; PEPTIDE; POLY(PROPYLENE FUMARATE); POLYGLACTIN; POLYMER; TP 508; UNCLASSIFIED DRUG; BONE CEMENT; FUMARIC ACID DERIVATIVE; MACROGOL DERIVATIVE; MICROSPHERE; PEPTIDE FRAGMENT; POLY(LACTIC GLYCOLIC ACID) POLY(ETHYLENEGLYCOL) COPOLYMER; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; POLYPROPYLENE; THROMBIN;

ARTICLE; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; DRUG FORMULATION; IN VITRO STUDY; INJECTION; PARTICLE SIZE; PRIORITY JOURNAL; BIODEGRADABLE IMPLANT; CHEMISTRY; DELAYED RELEASE FORMULATION; KINETICS; NON-PROGRAMMATIC; POROSITY;

NON-PROGRAMMATIC;

ABSORBABLE IMPLANTS; BONE CEMENTS; DELAYED-ACTION PREPARATIONS; FUMARATES; INJECTIONS; KINETICS; MICROSPHERES; PARTICLE SIZE; PEPTIDE FRAGMENTS; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYPROPYLENES; POROSITY; THROMBIN;

EID: 0037028063     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00261-4     Document Type: Article

References (39)

1. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. Evolution of bone transplantation: molecular, cellular, and tissue strategies to engineer human bone. Biomaterials. 17:1996;175-185.
2. Buck B.E., Malinin T.I., Brown M.D. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin. Orthop. 240:1989;129-136.
3. Urist M.R., Mikulski A., Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc. Natl. Acad. Sci. USA. 76:1979;1828-1832.
4. Babensee J.E., McIntire L.V., Mikos A.G. Growth factor delivery for tissue engineering. Pharm. Res. 17:2000;497-504.
5. Wozney J.M., Rosen V., Byrne M. Growth factors influencing bone development. J. Cell. Sci. 13:(1):1990;149-156.
6. Athanasiou K.A., Niederauer G.G., Agrawal C.M. Sterilization, toxicology, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. 17:1996;93-102.
7. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug. Del. Rev. 28:1997;5-24.
8. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lacide-co-glycolide) (PLGA) devices. Biomaterials. 21:2000;2475-2490.
9. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J. Bone Joint Surg. 74A:1992;659-671.
10. Smith J.L., Jin L., Parsons T., Turek T., Ron E., Philbrook C.M., Kenley R.A., Marden L., Hollinger J.O., Bostrom M.P.G., Tomin E., Lane J.M. Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2). J. Controlled Release. 36:1995;183-195.
11. Isobe M., Yamazaki Y., Oida S.I., Ishihara K., Nakabayashi N., Amagasa T. Bone morphogenetic protein encapsulated with a biodegradable and biocompatable polymer. J. Biomed. Mater. Res. 32:1996;433-438.
12. Hollinger J.O., Leong K. Poly(α-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials. 15:1996;187-194.
13. Lu L., Stamatas G.N., Mikos A.G. Controlled Release of transforming growth factor b1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. 50:2000;440-451.
14. Cleek R.E., Ting K.C., Eskin S.G., Mikos A.G. Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J. Controlled Release. 48:1997;258-268.
15. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., Hollinger J.O. Bone formation with use of rhBMP-2. J. Bone Joint Surg. 79A:1997;1778-1790.
16. Lo H., Ponticiello M.S., Leong K.W. Fabrication of controllled release biodegradable foams by phase separation. Tissue Eng. 1:1995;15-28.
17. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J. Controlled Release. 64:2000;91-102.
18. Whang K., Goldstick T.K., Healy K.E. A biodegradable polymer scaffold for the delivery of osteotropic factors. Biomaterials. 21:2000;2545-2551.
19. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 21:2000;2521-2527.
20. He S., Yaszemski M.J., Yasko A.W., Engel P.S., Mikos A.G. Injectable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-diacrylate. Biomaterials. 21:2000;2389-2394.
21. Peter S.J., Kim P., Yasko A.W., Miller M.J., Mikos A.G. Crosslinking characteristics of an injectable poly(propylene fumarate)/b-tricalcium phosphate biodegradable orthopaedic composite. J. Biomed. Mater. Res. 44:1999;314-321.
22. He S., Timmer M.D., Yaszemski M.J., Yasko A.W., Engel P.S., Mikos A.G. Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products. Polymer. 42:2001;1251-1260.
23. Peter S.J., Nolley M.S., Widmer J.E., Merwin M.J., Yaszemski M.J., Yasko A.W., Engel P.S., Mikos A.G. In vitro degradation of a poly(propylene fumarate)/b-tricalcium phosphate composite orthopaedic scaffold. Tissue Eng. 3:1997;207-215.
24. Peter S.J., Miller S.T., Zhu G., Yasko A.W., Mikos A.G. In vivo degradation of a poly(propylene fumarate)/b-tricalcium phosphate injectable composite scaffold. J. Biomed. Mater. Res. 41:1998;1-7.
25. Peter S.J., Lu L., Kim D.J., Mikos A.G. Marrow stromal osteoblasts function on a poy(propylene fumarate)/b-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials. 21:2000;1207-1213.
26. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Aufdermorte T.B., Mikos A.G. The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng. 1:1995;41-52.
27. Lewandrowski K.U., Gresser J.D., Wise D.L., White R.L., Trantolo D.J. Osteoconductivity of an injectable and bioresorbable poly(propylene glycol-co-fumaric acid) bone cement. Biomaterials. 21:2000;293-298.
28. Fisher J.P., Vehof J.W.M., Dean D., van der Waerden J.C.M., Holland T.A., Mikos A.G., Jansen J.A. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J. Biomed. Mater. Res. 59:2002;547-556.
29. Stiernberg J., Redin W.R., Warner W.S., Carney D.H. The role of thrombin and thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb. Haemost. 70:1993;158-162.
30. Sower L.E., Payne D.A., Meyers R., Carney D.H. Thrombin peptide, TP508, induces differential gene expression in fibroblasts through a nonprotyolitic activation pathway. Exp. Cell. Res. 247:1999;422-431.
31. J.T. Ryaby, R. Crowther, J. Yang, S. DiJorio, T. Breunig, J. Kinny, D. Carney, Repair of segmental defects in the rabbit with the thrombin-related peptide TP508, presented at 48th Annual Meeting of the Orthopaedic Research Society, Dallas, Texas, 2002.
32. Wilner G.D., Danitz M.P., Mudd M.S., Hsieh K.H., Fenton J.W.d. Selective immobilization of alpha-thrombin by surface bound fibrin. J. Lab. Clin. Med. 97:1981;403-411.
33. Shung A.K., Timmer M.D., Jo S., Engel P.S., Mikos A.G. Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst. J. Biomater. Sci. Polym. Ed. 13:2002;95-108.
34. Cleek R.L., Rege A.A., Denner L.A., Eskin S.G., Mikos A.G. Inhibition of smooth muscle cell growth in vitro by an antisense ogliodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J. Biomed. Mater. Res. 35:1997;525-530.
35. Box G., Hunter W., Stuart J. Statistics for Experimenters. 1978;John Wiley & Sons, New York.
36. Lucke A., Kiermaier J., Gopferich A. Peptide acylation by poly(alpha-hydroxy esters). Pharm. Res. 19:2002;175-181.
37. Fisher J.P., Holland T.A., Dean D., Engel P.S., Mikos A.G. Synthesis and properties of photo-crosslinked poly(propylene fumarate) scaffolds. J. Biomat. Sci. Polym. Ed. 12:2001;673-687.
38. Vehof J.W.M., Fisher J.P., Dean D., van der Waerden J.C.M., Spauwen P.H.M., Mikos A.G., Jansen J.A. Bone formation in transforming growth factor beta-1 loaded porous poly(propylene fumarate) discs in cranial defects in rabbits. J. Biomed. Mater. Res. 60:2002;241-251.
39. Winn S.R., Uludag H., Hollinger J.O. Sustained release emphasizing recombinant bone morphogenetic protein-2. Adv. Drug. Del. Rev. 31:1998;303-318.